The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus entry inhibitor
Preprint
Abstract
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emphasized the serious threat to human health posed by emerging coronaviruses. Effective antiviral countermeasures are urgently needed as vaccine development and deployment against an emerging coronavirus takes time, even in the best-case scenario. The green tea catechin, epigallocatechin gallate (EGCG), has broad spectrum antiviral activity. We demonstrate here that EGCG prevents murine and human coronavirus infection and blocks the entry of lentiviral particles pseudotyped with spike proteins from highly pathogenic coronaviruses, as well as a bat coronavirus poised to emerge into humans. We show that EGCG treatment reduces coronavirus attachment to target cell surfaces. Our results demonstrate the potential for the development of pan-coronavirus attachment inhibitors to protect against current and future emerging coronaviruses.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Epigallocatechin Gallate Inhibits the HIV Reverse Transcription StepAntiviral Chemistry and Chemotherapy, 2011
- Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell lineWorld Journal of Gastroenterology, 2011
- The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entryHepatology, 2010
- The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particlesJournal of Medical Virology, 2007
- Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapyJournal of Allergy and Clinical Immunology, 2006
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Recombinant Mouse Hepatitis Virus Strain A59 from Cloned, Full-Length cDNA Replicates to High Titers In Vitro and Is Fully Pathogenic In VivoJournal of Virology, 2005
- Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorptionJournal of Medical Virology, 2002
- Cell-Surface Heparan Sulfate Proteoglycan Mediates HIV-1 Infection of T-Cell LinesAIDS Research and Human Retroviruses, 1993
- Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption processJournal of General Virology, 1991